---
title: "Fourth vaccine dose"
image: "https:\/\/i.ytimg.com\/vi\/YqTGD9LHe9g\/hqdefault.jpg"
vid_id: "YqTGD9LHe9g"
categories: "Education"
tags: ["physiology","nursing","NCLEX"]
date: "2022-03-23T12:12:48+03:00"
vid_date: "2022-03-22T12:50:25Z"
duration: "PT26M5S"
viewcount: "549183"
likeCount: "21007"
dislikeCount: ""
channel: "Dr. John Campbell"
---
{% raw %}For young healthy adults, MODERNA SUBMITS AMENDMENT TO THE EMERGENCY USE AUTHORIZATION FOR AN ADDITIONAL BOOSTER DOSE OF ITS COVID-19 VACCINE IN THE U.S.<br /><br />(Pfizer, 65 and older for 4th shot)<br /><br /><a rel="nofollow" target="blank" href="https://twitter.com/moderna_tx/status/1504628697894113285">https://twitter.com/moderna_tx/status/1504628697894113285</a><br /><br /><a rel="nofollow" target="blank" href="https://investors.modernatx.com/news/news-details/2022/Moderna-Submits-Amendment-to-the-Emergency-Use-Authorization-for-an-Additional-Booster-Dose-of-its-COVID-19-Vaccine-in-the-U.S/default.aspx">https://investors.modernatx.com/news/news-details/2022/Moderna-Submits-Amendment-to-the-Emergency-Use-Authorization-for-an-Additional-Booster-Dose-of-its-COVID-19-Vaccine-in-the-U.S/default.aspx</a><br /><br />request to the U.S. Food and Drug Administration,<br /><br />for an amendment to the emergency use authorization,<br /><br />to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273),<br /><br />in adults 18 years of age and older who,<br /><br />have received an initial booster of any of the authorized or approved COVID-19 vaccines. <br /><br />(A booster dose of the Modern, 50 µg authorized for emergency use in the U.S. under EUA for adults 18 years and older)<br /><br />Clinical trials are ongoing for Moderna's Omicron-specific booster (mRNA-1273.529),<br /><br />and a bivalent Omicron-specific booster (mRNA-1273.214).<br /><br />Questions<br /><br />Will the 4th shot increase antibodies?<br /><br />Is it an emergency for a healthy 18 year old to get a 4th dose of vaccine today?<br /><br />Can beneficial endpoints be demonstrated for the individual?<br /><br />What n would be needed to demonstrate these beneficial outcomes?<br /><br />Will the 4th shot reduce T cell immunity for internal viral proteins?<br /><br />If someone has had omicron infection, will a 4th dose increase beneficial outcomes further?<br /><br />Is it time to end emergency shortcuts and get back to RCTS?<br /><br />Will there be guarantees a 4th dose will not be mandated once emergency use authorization is granted?<br /><br />Full FDA Approval of a COVID-19 Vaccine: What You Should Know<br /><br /><a rel="nofollow" target="blank" href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-know">https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/full-fda-approval-of-a-covid-19-vaccine-what-you-should-know</a><br /><br />The approval system for vaccines uses scientific data and exacting standards,<br />to ensure safe and effective vaccines<br />Review processes include<br /><br />Clinical trials<br />The FDA requires rigorous testing of vaccines through a series of clinical trials,<br /><br />to make sure they work and are safe before authorizing or approving them for the public. <br /><br />The laboratories that conduct the trials are independent from the vaccine companies and the government, <br /><br />process is not biased.<br /><br />Risks and benefits<br /><br />must demonstrate that the benefits of a vaccine are greater than its risks for those who will be vaccinated<br /><br />Continual monitoring<br /><br />the FDA may pause the administration of vaccine to do more studies,<br /><br />and ensure that the problem does not outweigh the vaccine’s benefit.<br /><br />Manufacturing guidelines<br /><br />test the vaccine doses in batches (lots),<br /><br />to ensure the quality and effectiveness of the vaccines remain consistent and reliable.<br /><br />UK 4th Jab<br /><br /><a rel="nofollow" target="blank" href="https://www.telegraph.co.uk/news/2022/03/20/fourth-covid-jabs-rolled-five-million-vulnerable-people-starting/?li_source=LI&amp;li_medium=liftigniter-onward-journey">https://www.telegraph.co.uk/news/2022/03/20/fourth-covid-jabs-rolled-five-million-vulnerable-people-starting/?li_source=LI&amp;li_medium=liftigniter-onward-journey</a><br /><br />Fourth Covid jabs to be rolled out to about five million vulnerable people starting from next week<br /><br />The Joint Committee on Vaccinations and Immunisations (JCVI)<br /><br /><a rel="nofollow" target="blank" href="https://www.gov.uk/government/news/jcvi-advises-a-spring-covid-19-vaccine-dose-for-the-most-vulnerable">https://www.gov.uk/government/news/jcvi-advises-a-spring-covid-19-vaccine-dose-for-the-most-vulnerable</a><br /><br />Another dose of Pfizer or Moderna, (six months after third dose)<br /><br />care home residents<br /><br />over-75s<br /><br />immunosuppressed people over 12 years{% endraw %}
